What is the difference between a beyond-use date and an expiration date?
An expiration date is assigned by a manufacturer after formal stability studies on a manufactured product. A beyond-use date (BUD) is assigned by the compounder to a compounded preparation using the limits in USP <795> and <797>, and is typically much shorter because compounded preparations have not undergone the same stability and sterility programs.
What are the USP 797 Category 2 BUD limits?
Category 2 CSPs range from 1 to 90 days depending on how they were made: aseptically processed without sterility testing is limited to 1–4 days at room temperature (depending on whether nonsterile starting components were used), 4–10 days refrigerated, and 45 days frozen. Sterility testing extends aseptically processed CSPs to 30/45/60 days and terminally sterilized CSPs to 45/60/90 days (room/refrigerated/frozen).
What is required for a Category 3 beyond-use date?
Category 3 CSPs — up to 180 days for terminally sterilized preparations stored frozen — require sterility testing on every batch plus enhanced requirements, including more frequent personnel requalification (every 3 months), sporicidal cleaning frequencies, specified garbing, and stability data supporting the assigned date.
How long can a multiple-dose vial be used after opening?
Once a multiple-dose container is punctured, it should not be used for more than 28 days unless the manufacturer specifies otherwise on the labeling.
Can stability data extend a compounded preparation’s BUD?
For nonsterile preparations under USP <795>, a longer BUD may be supported by a valid stability program within chapter limits. For sterile preparations under USP <797>, the category tables are ceilings — the path to longer dating is meeting the requirements of a higher category (for example, Category 3), not stability data alone.